SCHEMBL11758596

SCHEMBL11758596

CC1C2C(=O)OC(=O)C12C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.35
CYP3A4 P08684 3/20 0.35
MAPK1 P28482 3/20 0.35
HIF1A Q16665 2/20 0.35
LMNA P02545 2/20 0.35
CYP1A2 P05177 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
NFKB1 P19838 1/20 0.35
THPO P40225 1/20 0.35
PPM1B O75688 1/20 0.35
PTPN1 P18031 1/20 0.35
PPP1CC P36873 1/20 0.35
TFPI2 P48307 1/20 0.35
PPP5C P53041 1/20 0.35
PPP2CA P67775 1/20 0.35
PPP1CA P62136 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GMNN O75496 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13678802 1.00 TP53 (0.35) TP53CYP3A4MAPK1HIF1ALMNA
SCHEMBL12110769 0.74 TP53 (0.38) TP53CYP3A4MAPK1HIF1ALMNA
SCHEMBL910568 0.72 TP53 (0.50) TP53CYP3A4MAPK1HIF1ALMNA
SCHEMBL911568 0.72 TP53 (0.50) TP53CYP3A4MAPK1HIF1ALMNA
SCHEMBL16923817 0.72 TP53 (0.39) TP53CYP3A4MAPK1HIF1ALMNA
SCHEMBL23634039 0.72 TP53 (0.39) TP53CYP3A4MAPK1HIF1ALMNA
SCHEMBL10017614 0.72 TP53 (0.39) TP53CYP3A4MAPK1HIF1ALMNA
SCHEMBL23979209 0.70 MEN1 (0.32) TP53CYP3A4MAPK1HIF1ALMNA
SCHEMBL12359380 0.70 TP53 (0.35) TP53CYP3A4MAPK1HIF1ALMNA
SCHEMBL13515256 0.68 TP53 (0.33) TP53CYP3A4MAPK1HIF1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695149-B2 1,2,6-substituted benzimidazoles as flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-07-04 US disclosed
US-20160039790-A1 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-02-11 US disclosed
US-9089569-B2 1,2,6-substituted benzimidazoles as flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-28 US disclosed
US-20150119382-A1 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-04-30 US disclosed
US-8952177-B2 1,2,6-substituted benzimidazoles as FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2015-02-10 US disclosed
US-20140275029-A1 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-09-18 US disclosed
US-4009278-A Antimicrobial composition and method containing N-(3,5-dihalophenyl)-imide compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039790-A1 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS FEN1, FOXM1, F12 TP53 476/4885CYP3A4 9/4885MAPK1 4083/4885
US-20140275029-A1 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS FEN1, FOXM1, F12 TP53 476/4885CYP3A4 9/4885MAPK1 4083/4885
US-20150119382-A1 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS FEN1, FOXM1, F12 TP53 476/4885CYP3A4 9/4885MAPK1 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.